Core One Labs Inc (CLABF)
0.1072
-0.01
(-9.92%)
USD |
OTCM |
Jun 21, 14:48
Core One Labs Total Assets (Quarterly): 5.578M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.578M |
| September 30, 2023 | 5.511M |
| September 30, 2022 | 5.068M |
| June 30, 2022 | 5.422M |
| March 31, 2022 | 5.654M |
| December 31, 2021 | 5.969M |
| September 30, 2021 | 6.232M |
| June 30, 2021 | 6.436M |
| March 31, 2021 | 7.982M |
| December 31, 2020 | 7.469M |
| September 30, 2020 | 17.99M |
| June 30, 2020 | 14.66M |
| March 31, 2020 | 13.85M |
| December 31, 2019 | 13.63M |
| September 30, 2019 | 17.03M |
| June 30, 2019 | 20.05M |
| March 31, 2019 | 17.67M |
| December 31, 2018 | 15.47M |
| September 30, 2018 | 16.17M |
| June 30, 2018 | 17.44M |
| March 31, 2018 | 12.92M |
| December 31, 2017 | 10.44M |
| June 30, 2017 | 8.456M |
| March 31, 2017 | 1.689M |
| Date | Value |
|---|---|
| December 31, 2016 | 1.238M |
| September 30, 2016 | 1.732M |
| June 30, 2016 | 0.9384M |
| March 31, 2016 | 0.9175M |
| December 31, 2015 | 1.033M |
| September 30, 2015 | 1.541M |
| June 30, 2015 | 1.791M |
| March 31, 2015 | 0.3014M |
| December 31, 2014 | 0.3376M |
| September 30, 2014 | 0.4914M |
| June 30, 2014 | 0.5144M |
| March 31, 2014 | 0.0393M |
| December 31, 2013 | 0.0658M |
| September 30, 2013 | 0.182M |
| June 30, 2013 | 0.2627M |
| March 31, 2013 | 0.4894M |
| December 31, 2012 | 0.5364M |
| September 30, 2012 | 0.6071M |
| June 30, 2012 | 0.6606M |
| March 31, 2012 | 0.7677M |
| December 31, 2011 | 0.8065M |
| September 30, 2011 | 0.8654M |
| June 30, 2011 | 0.3972M |
| March 31, 2011 | 0.4221M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
5.068M
Minimum
Sep 2022
20.05M
Maximum
Jun 2019
9.908M
Average
6.952M
Median
Total Assets (Quarterly) Benchmarks
| Acasti Pharma Inc | 76.18M |
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 6.475M |
| Lexaria Bioscience Corp | 6.352M |
| InMed Pharmaceuticals Inc | 13.36M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.326M |
| Shareholders Equity (Quarterly) | 4.252M |
| Debt to Equity Ratio | 0.0443 |
| Current Ratio | 0.2534 |
| Net Debt Paydown Yield | -0.29% |